Heidi E. Roth

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Meta-Analysis Reveals Both the Promises and the Challenges of Clinical Metabolomics”.

Meta-Analysis Reveals Both the Promises and the Challenges of Clinical Metabolomics

Cancers(2022)10.3390/cancers14163992

N/A

0DataRank · unranked

22 citations

Robert Powers, Heidi E. Roth

Chemical shift variations in common metabolites

Journal of Magnetic Resonance(2022)10.1016/j.jmr.2022.107335

N/A

0DataRank · unranked

18 citations

Heidi E. Roth, Hannah Noel, Dennis Feng, Robert Powers, Fatema Bhinderwala

Peptidomics analysis reveals changes in small urinary peptides in patients with interstitial cystitis/bladder pain syndrome

Scientific Reports(2022)10.1038/s41598-022-12197-2

N/A

0DataRank · unranked

10 citations

Haowen Qiu, Bridget A. Tripp, Aline de Lima Leite, Heidi E. Roth, Jiří Adamec +3 more

Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies

Biomolecules(2022)10.3390/biom12101391

N/A

0DataRank · unranked

3 citations

Aline de Lima Leite, Nicolas Y. Palermo, Robert Powers, Heidi E. Roth

Best practices in NMR metabolomics: Current state

TrAC Trends in Analytical Chemistry(2023)10.1016/j.trac.2023.117478

N/A

0DataRank · unranked

32 citations

Erik R. Andersson, Amanda L. Bayless, Robert B. Brua, Mario C. Chang, Leo L. Cheng +23 more

Potential Metabolite Biomarkers of Multiple Sclerosis from Multiple Biofluids

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.3c00678

N/A

0DataRank · unranked

12 citations

Heidi E. Roth, Mary L. Filipi, Samantha Jack, Robert Powers, Fatema Bhinderwala